Nivolumab + Relatlimab

Category: Cancer

Nivolumab/relatlimab, sold under the brand name Opdualag, is a fixed-dose combination medication use to treat melanoma.[1] It contains nivolumab, a programmed death receptor-1 (PD-1) blocking antibody, and relatlimab, a lymphocyte activation gene-3 (LAG-3) blocking antibody.[1] It is given by intravenous infusion.[1] The combination was approved for medical use in the United States in March 2022.[1][2] Referenc... [wikipedia]

Related Brands

Drugs with the same active ingredients

Popular Topics

Opdivo (nivolumab) reviews

I had stage 3b subungual melanoma and after they did an amputation of my thumb and lymph nodes dissection, they lowered ...

Nivolumab treatments

Does anyone know of hospital in apples fl area offering immunotherapy for cancer namely nivolumab...